Research Library · Metabolic
What is GLP-3 RT?
GLP-3 RT (GLP-3) is a research compound studied in metabolic. Triple-receptor agonist hitting GLP-1, GIP, and glucagon in one molecule. Studied for metabolic re-composition beyond single-agonist protocols.
Overview
GLP-3 is the triagonist class — a single molecule that activates GLP-1, GIP, and glucagon receptors in one pass. Retatrutide-class compounds are the most-studied representative. The logic behind the class is simple: GLP-1 suppresses appetite and improves insulin sensitivity, GIP amplifies insulin response, and glucagon drives hepatic lipid oxidation. Hitting all three shifts the energy-balance equation in a way no single-receptor agonist has matched. What makes the triagonist class different: published Phase-2 data on retatrutide shows weight-loss outcomes beyond tirzepatide, combined with a lipid profile that reflects active fat oxidation rather than simple caloric restriction. IF the research question is metabolic re-composition — not just weight loss, but fat-mass reduction with lean-mass preservation — THEN the triagonist class is where the current literature is concentrated. SO GLP-3 belongs in any protocol looking at obesity, NAFLD, or diabetic dyslipidemia. Lyophilized, ≥99% purity, CoA shipped with every order.
Research areas
GLP-1 receptor pathway
<p>Activates pancreatic β-cell insulin secretion in a glucose-dependent manner, delays gastric emptying, and suppresses appetite via central mechanisms in the arcuate nucleus.</p>
GIP receptor pathway
<p>Potentiates insulin release at elevated glucose levels and modulates adipocyte lipid handling. The GIP arm of triagonists is what separates them from GLP-1 mono-agonists on metabolic-health endpoints.</p>
Glucagon receptor pathway
<p>Drives hepatic lipid oxidation and increases basal metabolic rate. The glucagon arm is the mechanism most credited for the lean-mass-preserving fat loss observed in the literature.</p>
Stability & reconstitution
<p>Reconstitute with bacteriostatic water for subcutaneous administration. Store reconstituted solution at 2–8°C; use within 30 days. Avoid freeze-thaw cycles.</p>
Published research
- Efficacy and safety of retatrutide, a GIP, GLP-1,…
PMID 42250575 — PubMed
- Retatrutide for the treatment of obesity, obstructive sleep…
PMID 41090431 — PubMed
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist,…
PMID 37385280 — PubMed
- Triple hormone receptor agonist retatrutide for metabolic…
PMID 38858523 — PubMed
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity
PMID 37366315 — PubMed
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity
PMID 37888926 — PubMed
Storage & handling
Lyophilized GLP-3 RTis stored at –20 °C protected from light. Once reconstituted with bacteriostatic water, store at 2–8 °C and use within 30 days for maximum stability.
Frequently asked questions
- What is GLP-3 RT?
- GLP-3 RT (GLP-3) is a research compound studied in the area of metabolic. Triple-receptor agonist hitting GLP-1, GIP, and glucagon in one molecule. Studied for metabolic re-composition beyond single-agonist protocols.
- What is the CAS number of GLP-3 RT?
- The CAS registry number of GLP-3 RT is 2381089-83-2.
- How should GLP-3 RT be stored?
- Lyophilized GLP-3 RT should be stored at –20 °C protected from light. Once reconstituted with bacteriostatic water, store at 2–8 °C and use within 30 days for maximum stability.
- How is the purity of GLP-3 RT verified?
- Every Woosh Labs batch of GLP-3 RT is independently tested by third-party HPLC and mass spectrometry, with a batch-specific Certificate of Analysis published verifying ≥99% purity.
- Is GLP-3 RT for human use?
- No. GLP-3 RT sold by Woosh Labs is strictly for in-vitro laboratory research by qualified professionals. It is not for human or veterinary use of any kind.
This page is for informational purposes for qualified researchers. All Woosh Labs products are for laboratory research use only and are not intended for human or veterinary use. Nothing here is medical advice or a claim of therapeutic effect.
